PHARMACEUTICAL COMPOSITION COMPRISING ENAVOGLIFLOZIN FOR PREVENTING OR TREATING CARDIOVASCULAR AGING DISEASES
Application
US20260097060A1
Kind: A1
Apr 09, 2026
Inventors
Sun-Hwa Park, Joon Seok Park, Ji-Soo Choi, Hye Young Ji, Min-Ho Oak, Ju-Young Ko, Saugat Shiwakoti, Dhakal Bikalpa
Abstract
The present invention relates to a pharmaceutical composition for use in preventing or treating cardiovascular aging diseases, comprising enavogliflozin as an active ingredient. Enavogliflozin of the present invention exhibits excellent effects in the prevention and treatment of endothelial dysfunction caused by vascular endothelial senescence, and cardiovascular aging diseases related thereto.
CPC Classifications
A61K 31/7048
A61P 9/00
Filing Date
2023-09-27
Application No.
19115424